Literature DB >> 19926352

Case report: pyoderma gangrenosum following Deep Inferior Epigastric Perforator (Diep) free flap breast reconstruction.

Y Rajapakse1, C B Bunker, A Ghattaura, N Jallali, J Henton, S E James, P A Harris, A E Searle.   

Abstract

Pyoderma gangrenosum is a rare but significant cutaneous disease that can lead to skin ulceration and necrosis. It is idiopathic but can occur post surgically. There has been only a limited number of case reports of PG complicating breast surgery. Copyright 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926352     DOI: 10.1016/j.bjps.2009.10.017

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Pyoderma Gangrenosum after Deep Inferior Epigastric Perforator Breast Reconstruction: Systematic Review and Case Report.

Authors:  Justin T Zelones; John F Nigriny
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-04-21

3.  Pyoderma Gangrenosum Masquerading as Necrotizing Infection after Autologous Breast Reconstruction.

Authors:  Tae Hwan Park; Kenneth L Fan; Elizabeth G Zolper; David H Song; Gabriel Del Corral
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-10

Review 4.  Dermatologic Complications Following Cosmetic and Reconstructive Plastic Surgery: A Systematic Review of the Literature.

Authors:  Peter J Nicksic; Rebecca L Farmer; Samuel O Poore; Venkat K Rao; Ahmed M Afifi
Journal:  Aesthetic Plast Surg       Date:  2021-07-06       Impact factor: 2.326

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.